ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,985Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 71

$1.59M Total Retail Price of All Prescriptions

Rank: 5 out of 71

647 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 647 patients filled at least one prescription for a schedule two drug, compared to an average of 12%.

Schedule Three
Controlled Substances

35% of this provider’s 647 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 25,763 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 30.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
OMEPRAZOLE 1,205 1,027 1 3
HYDROCODONE-ACETAMINOPHEN 1,186 1,134 S3 2 9
FUROSEMIDE 919 858 3 1
WARFARIN SODIUM 846 772 4 7
SIMVASTATIN 834 695 5 5
LISINOPRIL 824 731 6 6
LEVOTHYROXINE SODIUM 744 717 7 2
MIRTAZAPINE 743 719 8 15
DONEPEZIL HCL 695 678 9 10
POTASSIUM CHLORIDE 669 589 10 11
DIVALPROEX SODIUM 527 491 11 33
CARVEDILOL 527 497 11 25
AMLODIPINE BESYLATE 459 390 13 4
POLYETHYLENE GLYCOL 3350 411 359 14 27
NAMENDA 408 396 15 14
SERTRALINE HCL 404 336 16 17
PRAVASTATIN SODIUM 385 349 17 28
CITALOPRAM HBR 370 359 18 12
METOPROLOL TARTRATE 357 336 19 8
METOPROLOL SUCCINATE 346 307 20 16
FLUTICASONE PROPIONATE 320 236 21 35
PREDNISONE 319 285 22 36
GABAPENTIN 315 272 23 13
ALENDRONATE SODIUM 288 285 24 39
LOSARTAN POTASSIUM 286 248 25 21
QUETIAPINE FUMARATE 280 264 26 38
ZOLPIDEM TARTRATE 263 230 27 26
METFORMIN HCL 261 206 28 18
CYMBALTA 252 222 29 31
RANITIDINE HCL 242 197 30 36
TAMSULOSIN HCL 222 222 31 34
LANTUS 211 197 32 29
FINASTERIDE 206 205 33 77
CLOPIDOGREL 191 173 34 32
FENTANYL 191 187 S2 34 68
ATENOLOL 180 152 36 30
NOVOLOG 177 143 37 45
FENOFIBRATE 172 141 38 113
RISPERIDONE 172 130 38 24
AMOX TR-POTASSIUM CLAVULANATE 169 147 40 131
TRAZODONE HCL 163 127 41 23
IPRATROPIUM-ALBUTEROL 162 148 42 60
ISOSORBIDE MONONITRATE ER 160 148 43 44
SPIRIVA 151 140 44 62
ATORVASTATIN CALCIUM 151 146 44 20
FLUOXETINE HCL 150 97 46 76
ADVAIR DISKUS 148 115 47 47
DILTIAZEM 24HR CD 144 136 48 72
PROMETHAZINE HCL 139 126 R 49 85
SPIRONOLACTONE 138 124 50 58
LEVETIRACETAM 133 104 51 49
CLONIDINE HCL 127 101 52 48
ALLOPURINOL 123 110 53 41
CEPHALEXIN 119 110 54 87
ESCITALOPRAM OXALATE 119 94 54 46
TRIAMCINOLONE ACETONIDE 116 110 56 120
CARBIDOPA-LEVODOPA 114 114 57 66
METOCLOPRAMIDE HCL 114 100 57 100
SEROQUEL 114 107 57 92
OLANZAPINE 113 103 60 65
JANUVIA 113 106 60 98
TRAMADOL HCL 111 79 62 22
HYDRALAZINE HCL 108 106 63 55
OXYCONTIN 99 90 S2 64 128
NYSTOP 97 96 65 193
PAROXETINE HCL 97 91 65 84
INSULIN SYRINGE 94 80 67 119
PLAVIX 94 87 67 57
MELOXICAM 89 80 69 79
METFORMIN HCL ER 88 75 70 101
LIDODERM 87 80 71 73
PANTOPRAZOLE SODIUM 86 86 72 40
HUMALOG 84 79 73 116
LYRICA 81 60 74 109
VENLAFAXINE HCL ER 81 60 74 82
GLIPIZIDE 80 67 76 70
NYSTATIN 79 75 77 97
PHENYTOIN SODIUM EXTENDED 77 40 78 83
NEXIUM 74 67 79 42
NITROGLYCERIN PATCH 74 74 79 197
DIGOXIN 73 73 81 56
MUPIROCIN 73 68 81 126
LEVOFLOXACIN 72 66 83 63
FAMOTIDINE 72 49 83 78
LATANOPROST 72 72 83 114
VENLAFAXINE HCL 72 67 83 151
NOVOLOG MIX 70-30 70 66 87 161
EXELON 68 68 88 91
CIPROFLOXACIN HCL 67 63 89 52
CRESTOR 67 57 89 50
GLIPIZIDE XL 67 56 89 196
SYMBICORT 66 55 92 188
OXYBUTYNIN CHLORIDE ER 66 58 92 133
TRICOR 65 39 94 153
OXYCODONE-ACETAMINOPHEN 63 48 S2 95 51
GLIMEPIRIDE 63 63 95 74
CYCLOBENZAPRINE HCL 63 54 R 95 99
CLOTRIMAZOLE-BETAMETHASONE 62 52 98 186
LOVASTATIN 62 59 98 96
ROPINIROLE HCL 62 62 98 117
LEXAPRO 61 56 101 124
NIASPAN 60 56 102 243
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 56 102 86
DILTIAZEM ER 59 59 104 227
NOVOLOG FLEXPEN 59 56 104 223
MORPHINE SULFATE ER 58 42 S2 106 132
ABILIFY 55 26 107 102
NOVOLOG MIX 70-30 FLEXPEN 55 55 107 305
TRAMADOL HCL-ACETAMINOPHEN 54 42 109 165
NOVOLIN R 54 43 109 75
HYDROCHLOROTHIAZIDE 54 54 109 19
TRAVATAN Z 53 53 112 115
COLCRYS 53 40 112 123
MORPHINE SULFATE 53 45 S2 112 162
BENAZEPRIL HCL 50 37 115 89
BACLOFEN 50 39 115 67
GALANTAMINE HBR 50 43 115 168
ISOSORBIDE DINITRATE 50 50 115 219
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 23, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.